Crosswell Orthopaedic Care Ltd 16118813 false 2024-12-04 2025-12-31 2025-12-31 The principal activity of the company is orthopaedic surgery Digita Accounts Production Advanced 6.30.9574.0 true 16118813 2024-12-04 2025-12-31 16118813 2025-12-31 16118813 core:CurrentFinancialInstruments 2025-12-31 16118813 core:CurrentFinancialInstruments core:WithinOneYear 2025-12-31 16118813 core:FurnitureFittings 2025-12-31 16118813 core:PlantMachinery 2025-12-31 16118813 bus:SmallEntities 2024-12-04 2025-12-31 16118813 bus:AuditExemptWithAccountantsReport 2024-12-04 2025-12-31 16118813 bus:FilletedAccounts 2024-12-04 2025-12-31 16118813 bus:SmallCompaniesRegimeForAccounts 2024-12-04 2025-12-31 16118813 bus:RegisteredOffice 2024-12-04 2025-12-31 16118813 bus:Director1 2024-12-04 2025-12-31 16118813 bus:PrivateLimitedCompanyLtd 2024-12-04 2025-12-31 16118813 core:FurnitureFittings 2024-12-04 2025-12-31 16118813 core:PlantMachinery 2024-12-04 2025-12-31 16118813 countries:EnglandWales 2024-12-04 2025-12-31 iso4217:GBP xbrli:pure

Registration number: 16118813

Crosswell Orthopaedic Care Ltd
Unaudited Filleted Financial Statements
for the Period from 4 December 2024 to 31 December 2025

Crosswell Orthopaedic Care Ltd

Contents

Balance Sheet | 1
Notes to the Unaudited Financial Statements | 2 to 4

Crosswell Orthopaedic Care Ltd

(Registration number: 16118813)
Balance Sheet as at 31 December 2025

| Note | 2025 £
Fixed assets |  |
Tangible assets | 4 | 1,615
Current assets |  |
Debtors | 5 | 3,501
Cash at bank and in hand |  | 47,254
|  | 50,755
Creditors: Amounts falling due within one year | 6 | (18,913)
Net current assets |  | 31,842
Total assets less current liabilities |  | 33,457
Provisions for liabilities |  | (404)
Net assets |  | 33,053
Capital and reserves |  |
Called up share capital |  | 10
Retained earnings |  | 33,043
Shareholders' funds |  | 33,053

For the financial period ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and
• | The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 15 April 2026

......................................... Mr S C R Crosswell Director

Crosswell Orthopaedic Care Ltd

Notes to the Unaudited Financial Statements for the Period from 4 December 2024 to 31 December 2025

1 | General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
2 Old Bath Road
Newbury
Berkshire
RG14 1QL
England

2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the provision of services in the ordinary course of the company's activities.

Tax

The tax expense for the period comprises current tax payable and deferred tax.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.
Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Crosswell Orthopaedic Care Ltd

Notes to the Unaudited Financial Statements for the Period from 4 December 2024 to 31 December 2025

Asset class | Depreciation method and rate
Plant and Machinery | 20% Straight Line

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

3 | Staff numbers

The average number of persons employed by the company (including the director) during the period, was 1.

Crosswell Orthopaedic Care Ltd

Notes to the Unaudited Financial Statements for the Period from 4 December 2024 to 31 December 2025

4 | Tangible assets

| Fixtures and fittings £ | Plant and machinery £ | Total £
Cost or valuation
Additions | 757 | 915 | 1,672
At 31 December 2025 | 757 | 915 | 1,672
Depreciation
Charge for the period | 57 | - | 57
At 31 December 2025 | 57 | - | 57
Carrying amount
At 31 December 2025 | 700 | 915 | 1,615

5 | Debtors

Current | 2025 £
Prepayments | 3,501
| 3,501

6 | Creditors

Creditors: amounts falling due within one year

| 2025 £
Due within one year |
Taxation and social security | 15,237
Other creditors | 3,676
| 18,913

7 | Related party transactions

Other transactions with the director

S C R Crosswell had a loan account with the company. At the balance sheet date the amount due to S C R Crosswell was £2,548.